Keyphrases
Protein Aggregation
100%
Mutant SOD1
100%
Protein Toxicity
100%
PC12 Cells
100%
1,3-Cyclohexanedione
100%
Amyotrophic Lateral Sclerosis
83%
Structural Modification
33%
Neuronal Cells
33%
SOD1G93A
33%
PC12
33%
Mouse Model
16%
Pathophysiology
16%
Neurodegenerative Diseases
16%
Novel Therapeutics
16%
Blood-brain Barrier
16%
FDA-approved Drugs
16%
Pharmacokinetic Properties
16%
Cell Activity
16%
Zn-superoxide Dismutase
16%
Superoxide Dismutase 1 (SOD1)
16%
Family Forms
16%
Motor Neuron
16%
Synthetic Routes
16%
EC50
16%
High Solubility
16%
High-throughput Screening Assays
16%
Bioactive Compounds
16%
Therapeutic Candidates
16%
New Analogs
16%
Life Extension
16%
Cell Permeability
16%
Metabolic Potential
16%
Primary Cortical Neurons
16%
Cell Penetration
16%
Riluzole
16%
Plasma Instabilities
16%
3-dione Derivatives
16%
Neuroscience
SOD1
100%
Protein Aggregation
100%
Cyclohexane
100%
Amyotrophic Lateral Sclerosis
83%
Riluzole
16%
Neurodegenerative Disorder
16%
Blood Brain Barrier
16%
Copper Zinc Superoxide Dismutase
16%
Cell Activity
16%
Cell Membrane Permeability
16%
Blood Plasma
16%
Pharmacokinetics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclohexane
100%
Amyotrophic Lateral Sclerosis
83%
Mouse Model
16%
High-Throughput Screening
16%
Copper Zinc Superoxide Dismutase
16%
Riluzole
16%
Pathophysiology
16%
Degenerative Disease
16%
Blood-Brain Barrier
16%
Pharmacokinetics
16%
EC50
16%
Diseases
16%